A new 'In Discussion With' episode has pharmacist Sehar Shahid weighing in on obesity risk. The preview gives little beyond the topic.
Recap by typeshit. Post by Facebook on Facebook.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
HIRA says it can't yet predict an outcome. Hanmi is readying its homegrown obesity drug, and some expect a full price fight in Korea.
Sehar Shahid explains how she runs a weight loss clinic out of her internet pharmacy, 24-hour Pharmacy. Few other details are given.
Loading…